Wilms Joris

Insider profile

Performance

Overall performance
3.2

Performance over holding periods
3.2
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Wilms Joris's trades of Y-mAbs Therapeutics, Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-27 2024-08-26 S Sale
98,871 +11.8%
80.03
US$1,451,812
98,871 +11.8% 80.03 US$1,451,812
2024-08-26 2024-08-26 PrS Proposed sale
93,256
47.00
US$2,855,298
93,256 47.00 US$2,855,298